Aflunov(r) Prepandemic Influenza Vaccine, H5N1 (surface antigen, inactivated, adjuvanted) 0.5mL pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

aflunov(r) prepandemic influenza vaccine, h5n1 (surface antigen, inactivated, adjuvanted) 0.5ml pre-filled syringe

seqirus pty ltd - influenza virus haemagglutinin -

Pandemrix New Zealand - English - Medsafe (Medicines Safety Authority)

pandemrix

glaxosmithkline nz limited - influenza virus haemagglutinin type a/vietnam/1194/2004 nibrg-14 (h5n1) 3.75ug - suspension for injection - 3.75 mcg - active: influenza virus haemagglutinin type a/vietnam/1194/2004 nibrg-14 (h5n1) 3.75ug excipient: dibasic sodium phosphate dodecahydrate magnesium chloride monobasic potassium phosphate octoxinol polysorbate 80 potassium chloride sodium chloride thiomersal water for injection d-alpha tocoferol dibasic sodium phosphate dodecahydrate monobasic potassium phosphate polysorbate 80 potassium chloride sodium chloride squalene water for injection - indicated for prophylaxis of influenza in an officially declared pandemic situation. the vaccine may only be marketed, or distributed in accordance with the directives contained in the current version of the new zealand influenza pandemic action plan.

Aflunov Suspension for Injection 0.5ml in Pre-filled syringe Singapore - English - HSA (Health Sciences Authority)

aflunov suspension for injection 0.5ml in pre-filled syringe

seqirus pte. ltd. - influenza virus surface antigens (haemagglutinin and neuraminidase) a/turkey/turkey/1/05 (h5n1)-like strain used (nibrg-23) - injection, suspension - > or = 7.5 ug ha - influenza virus surface antigens (haemagglutinin and neuraminidase) a/turkey/turkey/1/05 (h5n1)-like strain used (nibrg-23) 7.5 ug ha/0.5 ml

Adjupanrix Pandemic Influenza Vaccine (split virion inactivated AS03 adjuvanted) Singapore - English - HSA (Health Sciences Authority)

adjupanrix pandemic influenza vaccine (split virion inactivated as03 adjuvanted)

glaxosmithkline pte ltd - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) - injection, emulsion - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) 3.75 µg haemagglutinin/dose

Prepandemic Influenza Vaccine, H5N1 (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics 0.5mL pre-fille Australia - English - Department of Health (Therapeutic Goods Administration)

prepandemic influenza vaccine, h5n1 (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics 0.5ml pre-fille

seqirus pty ltd - influenza virus haemagglutinin -

Pandemrix European Union - English - EMA (European Medicines Agency)

pandemrix

glaxosmithkline biologicals s.a. - split influenza virus inactivated, containing antigen equivalent to a/california/07/2009 (h1n1)-derived strain used nymc x-179a - influenza, human; immunization; disease outbreaks - influenza vaccines - prophylaxis of influenza caused by a (h1n1)v 2009 virus. pandemrix should only be used if the recommended annual seasonal trivalent / quadrivalent influenza vaccines are not available and if immunisation against (h1n1)v is considered necessary (see sections 4.4 and 4.8).pandemrix should be used in accordance with official guidance.

MANUGEL 85- ethanol gel United States - English - NLM (National Library of Medicine)

manugel 85- ethanol gel

laboratoires anios - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m), phenoxyethanol (unii: hie492zz3t) (phenoxyethanol - unii:hie492zz3t) - alcohol 400 ml in 500 ml - thixotropic hydroalcoholic gel for hygienic treatment and surgical disinfetion by hand-rubbing. ethanol (700 mg/g ie 755 ml/l - n° cas 64-17-5) in the presence of thickening, moisturizing and emollient agents, and water.  without purfume nor coloring. a ready-to-use gel.  hygienic treatment: 3 ml* for a hand-rubbing time of 30 seconds.  surgical disinfection: 2 x 3 ml* for a hand-rubbing time of two times 45 seconds.  well-apply and rub until complete dry.  do not rinse.  (*3 ml = 2 pump squirts).  for application in operating theater and frequency of use, refer to the protocol of the establishment. hygienic treatment: 3 ml* for a hand-rubbing time of 30 seconds. surgical disinfection: 2 x 3 ml* for a hand-rubbing time of two times 45 seconds. well-apply and rub until complete dry. do not rinse. (*3 ml = 2 pump squirts). thixotropic hydroalcoholic gel for hygienic treatment and surgical disinfetion by hand-rubbing

Aflunov European Union - English - EMA (European Medicines Agency)

aflunov

seqirus s.r.l.  - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza-a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/turkey/turkey/1/05 (h5n1)-like strain.aflunov should be used in accordance with official recommendations.

Prepandrix European Union - English - EMA (European Medicines Agency)

prepandrix

glaxosmithkline biologicals s.a. - a/indonesia/05/2005 (h5n1) like strain used (pr8-ibcdc-rg2) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza-a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared with h5n1 subtype strains.prepandrix should be used in accordance with official guidance.

Artinibsa 40mg/ml+0,01mg/ml solution for injection Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

artinibsa 40mg/ml+0,01mg/ml solution for injection

laboratories inibsa s.a. - articaine (articaine hydrochloride), epinephrine (epinephrine tartrate) - solution for injection - 40mg/ml+0,01mg/ml